Estimation of glomerular filtration rate in cancer patients

Citation
Jg. Wright et al., Estimation of glomerular filtration rate in cancer patients, BR J CANC, 84(4), 2001, pp. 452-459
Citations number
34
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
BRITISH JOURNAL OF CANCER
ISSN journal
00070920 → ACNP
Volume
84
Issue
4
Year of publication
2001
Pages
452 - 459
Database
ISI
SICI code
0007-0920(200102)84:4<452:EOGFRI>2.0.ZU;2-X
Abstract
The frequent need to obtain an estimate of renal function in cancer patient s, not least for targeting carboplatin dose, has led to a number of approac hes to estimate glomerular filtration rate (GFR). This study aimed to devel op a simple and reliable method to estimate GFR using readily-available pat ient characteristics. Data from 62 patients with estimates of Cr-51-EDTA cl earance were analysed to determine the most appropriate formula relating th is method of measuring GFR to patient characteristics. The population pharm acokinetics of Cr-51-EDTA were analysed using NONMEM to evaluate the influe nce of each covariate. The formulae derived were then validated using a fur ther 38 patients and compared with those obtained using existing formulae. Cr-51-EDTA clearance (GFR) was positively related to Dubois surface area, n egatively related to age, and inversely related to serum creatinine (SCr). Females had lower Cr-51-EDTA clearance than males. The enzymatic method of SCr assay gave more reliable results than the Jaffe colorimetric method. A measure of creatine kinase significantly improved the estimation of GFR. Th e new formula produced estimates of GFR which were less biased (Mean Predic tion Error = -3%) and more precise (Mean Absolute Prediction Error = 12%) t han Cockcroft and Gault (-8% and 16%) or Jelliffe (-15% and 19%) estimates. The formulae developed here can be used to provide reliable estimates of G FR, particularly in regard to targeted dosing of carboplatin. (C) 2001 Canc er Research Campaign.